FluGen Initiates a Phase 1 Clinical Trial of the RedeeFlu™ Universal Influenza Vaccine in Healthy Subjects MADISON, WI, July 27, 2016 – FluGen Inc., a clinical-stage biopharmaceutical company focused on… read more →
Industry Veterans Dan Stinchcomb and C. Boyd Clarke Join FluGen’s Board of Directors FluGen Inc., a biotechnology company developing a novel “universal” influenza vaccine, has completed a $12 million Series… read more →
From the Milwaukee Journal Sentinel: http://scanmail.trustwave.com/?c=4062&d=kpTB1NHFhyUH4GF7iyUlRHSmmW-voEUD7G9McOkf0g&s=243&u=http%3a%2f%2fon%2ejsonl%2ein%2f1y04cj4 University of Wisconsin-Madison scientist Yoshi Kawaoka was researching influenza viruses that were killing chickens in the mid-’90s when he picked up a new bestseller,… read more →
The University of Wisconsin-Madison’s Yoshihiro Kawaoka has been recognized as a 2014 Popular Mechanics Breakthrough Award recipient for his efforts to understand and prevent pandemic influenza. He joins a list… read more →
FluGen-Arecor Partnership Enhances Promise of Universal Flu Vaccine Through Funding Award from the UK’s innovation agency, the Technology Strategy Board Cambridge, UK – Arecor Ltd of Cambridge, England received the “green… read more →